إعلان
إعلان

CLDX

CLDX logo

Celldex Therapeutics, Inc

27.36
USD
برعاية
+0.01
+0.03%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

27.36

0.00
-0.01%

تقارير أرباح CLDX

النسبة الإيجابية المفاجئة

CLDX تفوق 28 من 39 آخر التقديرات.

72%

التقرير التالي

بيانات التقرير القادم
٢٥ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$1.62M
/
-$1.01
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
--
التغير الضمني من Q4 24 (Revenue/ EPS)
+37.70%
/
+42.25%

Celldex Therapeutics, Inc earnings per share and revenue

On ١٠ نوفمبر ٢٠٢٥, CLDX reported earnings of -1.01 USD per share (EPS) for Q3 25, missing the estimate of -0.91 USD, resulting in a -9.94% surprise. Revenue reached --, compared to an expected 1.01 مليون, with a -100.00% difference. The market reacted with a +7.50% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 17 المحللين forecast an EPS of -1.01 USD, with revenue projected to reach 1.62 مليون USD, implying an زيادة of 0.00% EPS, and -- of --% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Celldex Therapeutics, Inc reported EPS of -$1.01, missing estimates by -9.94%, and revenue of $0.00, -100% below expectations.
The stock price moved up 7.5%, changed from $22.67 before the earnings release to $24.37 the day after.
The next earning report is scheduled for ٢٥ فبراير ٢٠٢٦.
Based on 17 المحللين, Celldex Therapeutics, Inc is expected to report EPS of -$1.01 and revenue of $1.62M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان